The effects of aspirin on gastric acid secretion were studied in isolated rabbit parietal cells (PC). Aspirin (i0-5 M) potentiated histamine-, dibutyryl cyclic AMP (dbcAMP)-, forskolin-and 3-isobutyl-1-methylxanthine-stimulated acid secretion without affecting basal acid secretion. Augmentation of secretagogue-stimulated acid secretion by aspirin was dependent on calcium (Ca2") since potentiation was blocked by removal of extracellular Ca2+ ([Ca2+1.) or addition of the calcium antagonist lanthanum chloride. Using the Ca2+ probe fura-2, aspirin (10-6-2 X lo-5 M) rapidly increased intracellular free Ca2" concentration ([Ca2+I,) Aspirin did not affect several other signal transduction sites involved in stimulus-secretion coupling, including the H2 receptor, intracellular cyclic AMP (cAMP), inositol 1,4,5, triphosphate (IP3) and H',K+-ATPase. Aspirin decreased PC prostaglandin E2 (PGE2) content by 98%. Exogenous dimethyl PGE2 (dmPGE2) inhibited both histamine-stimulated acid secretion and its enhancement by aspirin. In contrast, dmPGE2 abolished aspirin-induced potentiation of dbcAMP-stimulated acid secretion by augmenting the dbcAMP-stimulated response. These results indicate that aspirin acts at a site beyond the adenylate cyclase/cAMP system and before the proton pump, presumably by releasing Ca2+ from an IP3-independent intracellular storage pool and by inhibiting PGE2 generation. (J. Clin. Invest. 1990. 86:400-408.)
receiving aspirin (3), the underlying mechanism for gastric mucosal damage remains unclear (1) .
We and others have observed that salicylate and nonsalicylate nonsteroidal anti-inflammatory drugs (NSAIDs) stimulated basal acid secretion in vivo and potentiated histaminestimulated acid secretion in vivo and in vitro (4) (5) (6) (7) (8) , suggesting that enhanced gastric acid secretion could play a role in the pathogenesis of NSAIDs-induced gastrointestinal mucosal injury.
Secretion of acid is regulated by specific agonists (i.e., histamine, acetylcholine, and gastrin) bound to cell membrane receptors via at least two intracellular second messengers, cyclic AMP (cAMP) and calcium (Ca"), the latter being regulated by inositol 1,4,5-triphosphate (1P3) and 1,2-diacylglycerol (DAG) (9, 10) . Prior data suggest that a rise in intracellular free The results reported here implicate an intracellular Ca2+-dependent pathway as a mediator of aspirin-induced augmentation of secretagogue-stimulated acid secretion and this potentiation may be modulated by PGE2.
Methods
Isolation ofglands and cells. Fundic glands (FG) and PC were isolated from New Zealand white rabbits (weighing 2.5-3.0 kg) using the method of Berglindh and Obrink (13) and a modification of Berglindh's method (14) , as we previously reported (15). Briefly, PC were separated by enzyme digestion and purified to 80-90% by Nycodenz density gradient centrifugation. The PC were washed three times with respiratory medium (RM), pH 7.4, containing (in millimolar): NaCl, 132, KCl, 5.4, NaH2PO4, 1.0, Na2HPO4, 5, MgSO4, 1.2, CaCI2, 1.0, D-glucose, 11, and bovine serum albumin, 2 mg/ml. In some experiments PC were washed once with Ca2+-free RM Aminopyrine (AP) uptake ratio. AP uptake determinations were performed as previously described ( 16) . After a 10-min preincubation, 1 . Abbreviations used in this paper: AP, aminopyrine; ASA, aspirin;
[Ca>]i, intracellular free calcium concentration; [Ca"]., extracellular calcium; DAG, 1,2,-diacylglycerol; dbcAMP, N6, 2'-O-dibutyryl adenosine 3,5-cyclic monophosphate; dmPGE2, 16,16-dimethyl PGE2; FG, fundic glands; fura-2/AM, fura-2 acetoxymethyl ester; IBMX, 3-isobutyl-1-methylxanthine; IP3, inositol 1,4,5-trophosphate; La+3, lanthanum chloride; PC, parietal cells; PKA, protein kinase A; PKC, protein kinase C; RM, respiratory medium; SA, salicylic acid. an aliquot of FG or PC was incubated with ['4C]aminopyrine (118 mCi/mmol) at a concentration of 0.1 Ci/ml for 10 min at 37OC. 1-ml aliquots of FG or PC were added to the various concentrations of test agents, incubated for 20 min at 370C with shaking, the suspensions centrifuged, and supernatant removed. The pellet was solubilized and counted in a liquid scintillation counter (Beckman LS-355). The AP accumulation was determined as the ratio of intra-to extracellular AP.
Measurement of [Ca3+]J. PC (106 cells/ml) were loaded with the fluorescent Ca2" indicator fura-2/AM, using the method of Negulescu and Machem (I 1). In some experiments PC were washed three times with Ca2+-free RM containing 0.2 mM EGTA to deplete both intraand extracellular Ca2' and used for fluorescent measurement, according to Malinowska et al. (17) . Ca2' signals were obtained at 370C using a modular fluorometer system (Fluorolog 2, model CM3) coupled to a Spex Datamate microcomputer. Fluorescence was monitored at 340/380-nm excitation and 510-nm emission (18, 19) . Data points were collected every 4 s. Calibration was performed using 1% (vol/vol) Triton X-100 and 10 mM EGTA for maximal and minimal fluorescence, respectively. Autofluorescence of each control sample was subtracted from their respective experimental values.
[Ca2+], concentration was calculated as described previously (18, 19) .
Addition of aspirin at any concentration to the Ca2+/fura-2 buffer did not affect the Ca2+/fura-2 fluorescence. However, in control PC buffer without fura-2, aspirin exhibited autofluorescence between aspirin concentrations of 2 X 1i-5 to 10-4 M. Autofluorescence of aspirin was subtracted from the experimental value of Ca2+/fura-2 Aspirin and salicylic acid were dissolved in 50-100 ul of 10 mM NaOH and adjusted to pH 7.5 by 1 mM HCl after dilution in water. Fura-2/AM, IBMX, dmPGE2 and forskolin were dissolved in dimethyl sulfoxide in such a way that the final experimental concentration was not more than 1%. Statistical evaluation. The n in all data equals the number of animals used. Data expressed as mean±SEM. To determine statistical significance, we used either the Student t test for paired experimental studies or ANOVA, followed by the Student Newman-Keuls test for multiple comparisons with the same control. Significance was accepted at P < 0.05.
Results
Effects of aspirin on AP uptake ratio. Aspirin ( potentiated by aspirin 32%, 34%, and 56%, respectively, compared to their controls. Compared to histamine-stimulated AP uptake (100%), carbachol (10-4 M)-stimulated AP uptake was much lower (23%). Aspirin did not potentiate carbachol-stimulated AP uptake in contrast to its enhancement of other secretagogues (Fig. 2) . Fig. 3 demonstrates that histamine-stimulated AP uptake and its potentiation by aspirin was blocked by the H2 receptor antagonist, cimetidine (2 X l0-4 M). In contrast, cimetidine was unable to block dbcAMP-stimulated AP uptake and its potentiation by aspirin, indicating that cimetidine inhibited histamine stimulation per se rather than the potentiating effect of aspirin. Fig. 4 shows the effects of aspirin on basal and histaminestimulated AP uptake either in the presence or absence of La3+. Aspirin increased AP uptake by 63% above histamine stimulation within 30 min without affecting basal AP uptake. Histamine-stimulated AP uptake was reduced by 20% with respect to its control level after 30 min treatment with La3+ (Fig. 4) . When La3+ was added in conjunction with aspirin after 30 min stimulation of PC by histamine, a significant reversal of the aspirin-induced potentiation of stimulated AP uptake occurred at 15 min and continued for the next 15 min to the level of histamine with La3+. These results indicate that intracellular Ca2+ is important for the initial potentiation of C. (Table I) . Aspirin-induced augmentation of [Ca2+], was dose dependent, as shown in Fig. 6 . Lineweaver-Burk plot of the data shows that the half maximum effect of aspirin occurred at a concentration of 2.5 X 10-6 M. (Table I) . Carbachol, salicylate and aspirin did not alter resting cAMP levels and histamine-stimulated cAMP levels were also unaffected by aspirin (Table I ). It appears therefore that the potentiation of secretagogue-induced acid secretion by aspirin is not dependent on cAMP generation.
Effect of aspirin on inositol phosphates synthesis. Inositol 1,4,5 triphosphate (UP3) synthesis in PC is shown in Table I after 5 and 30 min treatment with different secretagogues and aspirin. Carbachol, as previously observed (21) increased at 5 min 1 monophosphate (26±3%, P < 0.01), inositol 1,4 biphosphate (26±4%, P < 0.01) and IP3 (54±11%, P < 0.05, Table I ) with respect to their controls. Aspirin, histamine and aspirin with histamine-failed to alter phosphoinositide turn- (10 s Effects of aspirin and salicylic acid on PC PGE2 content.
Aspirin reduced PC PGE2 content by 98% after 5-30 min treatment, in the presence and absence of histamine (Fig. 7) . Both histamine and salicylic acid failed to alter significantly PGE2 levels. Effect ofdmPGE2 on AP uptake. Fig. 8 shows that exogenous dmPGE2 (10-7-10-5 M) inhibited histamine-stimulated AP uptake (-30% of its control) and its potentiation by aspirin to the same extent. On the other hand, dbcAMP-stimulated AP uptake and its potentiation by aspirin were unaffected by dmPGE2 at a concentration of (Fig. 8) . However, at a higher concentration (lO-' M), dmPGE2 increased significantly dbcAMP-stimulated AP uptake to a level not different from dbcAMP and aspirin-induced AP uptake, indicating that dmPGE2 blocked aspirin-induced potentiation of the dbcAMP-stimulated AP response.
Discussion
We have shown that aspirin potentiates secretagogue-stimulated acid secretion in PC, as previously demonstrated for NSAIDs in vivo and in vitro (4) (5) (6) (7) (8) . Several possibilities exist concerning the mechanisms by which aspirin affects stimulussecretion coupling and thereby potentiates PC function. Stimulus-secretion coupling in PC involves multiple second messenger pathways that may act synergistically. These signal transduction sites include either H2 or muscarinic receptors interacting with specific agonists (e.g., histamine and carbachol) which stimulate intracellular cAMP, as regulated by PGE2, or initiate hydrolysis of membrane phospholipids. The former receptor activates cAMP-dependent protein kinase A (PKA) and the latter leads to elevation of cellular IP3 and DAG, which, respectively, mobilizes intracellular Ca2+ (26) and activates PKC (27) . Protein kinase activation can phosphorylate intracellular proteins (28, 29) and produce multiple effects on PC secretory activity (27) . The final step responsible for acid exiting from PC is via the proton pump, H+,K+-ATPase.
Aspirin did not appear to involve the H2 receptor or adenylate cyclase/cAMP system since cimetidine failed to block the potentiation of dbcAMP-stimulated AP uptake by aspirin (Fig. 3) and aspirin potentiated forskolin, IBMX-and dbcAMP-stimulated AP uptakes (Fig. 2) . These observations support a regulatory role for aspirin in conjunction with secretagogues distal to the site of the catalytic subunit of adenylate cyclase activation. It also appears unlikely that the actions of aspirin were mediated by the stimulatory or inhibitory guanine-nucleotide-binding proteins because aspirin did not affect PC cAMP content (Table I) .
Potentiation (Fig. 4) . The elevation in [Ca2+]i induced by carbachol and histamine was blocked by atropine and cimetidine, respectively, as previously described (11, 17) . The relationship between aspirin-induced Ca2+ flux, which occurs within seconds and augmentation ofsecretagogue-stimulated acid secretion, which can be measured within 15 min (Fig. 4) Aspirin is a strong cyclooxygenase inhibitor and reduced PGE2 content in PC by 98% (Fig. 7) . The decrease in PGE2 levels induced by aspirin could augment acid secretion in PC as we observed in the chambered frog gastric mucosa (37) and for indomethacin in vivo (5) . However, in PC basal acid secretion was unaffected by this degree of reduction in PGE2 levels. Histamine-stimulated acid secretion is inhibited by exogenous PGE2 (16, 38) without altering acetylcholine or gastrin-stimulated acid secretion (38) . Therefore, we examined whether aspirin's potentiation of histamine-and dbcAMP-stimulated AP uptakes could be ameliorated by exogenous dmPGE2. Such treatment inhibited by -30% the acid response to histamine alone and its potentiation by aspirin to the same ex-tent. However, dbcAMP-stimulated AP uptake was augmented by dmPGE2 to the same level as with dbcAMP + aspirin, suggesting prevention of the aspirin-potentiating effect. Soll (38) also found that PGE2 increased dbcAMP + gastrin-stimulated AP uptake. The effects of aspirin on prestimulated secretion could be mediated by its ability to inhibit PGE2 generation, since dmPGE2 prevented aspirin-induced potentiation of secretagogue-stimulated acid secretion (Fig. 8) .
It is unlikely that any one mechanism is entirely responsible for the aspirin-induced enhancement of prestimulated acid secretion. We postulate that aspirin interacted at a site(s) beyond adenylate cyclase and before H+,K+-ATPase as supported by our data showing that potentiation of secretagoguestimulated acid secretion by aspirin did not further enhance intracellular cAMP and aspirin did not activate H+,K+-ATPase. Our measurements of inositol phosphates turnover suggests that aspirin releases Ca2+ from IP3-independent intracellular storage pools. Moreover, a protein kinase inhibitor, isoquinolinylsulfonamide, previously reported to augment secretagogue-stimulated acid secretion in PC (39, 40) , mimicked the potentiating effects of aspirin on histamine-and dbcAMP-stimulated acid secretion (unpublished observations). These observations implicate involvement of PKA or PKC in the potentiation of secretagogue-stimulated acid secretion. Further evidence is necessary before conclusions can be made regarding the site(s) of action of aspirin in PC.
The proposed mobilization of Ca2+ in PC by aspirin and its subsequent augmentation of stimulated acid secretion may, in part, underlie the pathogenesis of aspirin-induced gastric mucosal injury. While decreased mucosal prostanoid synthesis may play a contributory role in the mechanism of NSAIDsinduced gastric damage (41, 42) , recent evidence questions the strict relationships between the development of mucosal injury, enhanced gastric acid secretion and inhibition of prostaglandin production (43) (44) (45) (46) (47) (48) .
